Long Term Debt Summary of BetterLife Pharma Inc.

BetterLife Pharma Inc.'s latest annual long term debt in 2024 was 245.23 Thousand CAD , down -25.54% from previous year.
BetterLife Pharma Inc.'s latest quarterly long term debt in 2024 FY was 245.23 Thousand CAD , down -44.29% from previous quarter.
BetterLife Pharma Inc. reported annual long term debt of 440.17 Thousand CAD in 2023, down -51.04% from previous year.
BetterLife Pharma Inc. reported annual long term debt of 899.07 Thousand CAD in 2022, down 0.0% from previous year.
BetterLife Pharma Inc. reported quarterly long term debt of 245.23 Thousand CAD for 2024 FY, down -44.29% from previous quarter.
BetterLife Pharma Inc. reported quarterly long term debt of 245.23 Thousand CAD for 2024 Q4, down -55.44% from previous quarter.

Annual Long Term Debt Chart of BetterLife Pharma Inc. (2024 - 2009)

Historical Annual Long Term Debt of BetterLife Pharma Inc. (2024 - 2009)

Year	Long Term Debt	Long Term Debt Growth
2024	245.23 Thousand CAD	-25.54%
2023	440.17 Thousand CAD	-51.04%
2022	899.07 Thousand CAD	0.0%
2021	- CAD	-100.0%
2020	4.63 Million CAD	328916.69%
2019	1408.49 CAD	-99.43%
2018	245.37 Thousand CAD	0.0%
2017	- CAD	0.0%
2016	- CAD	0.0%
2015	- CAD	0.0%
2014	- CAD	0.0%
2013	- CAD	0.0%
2012	- CAD	0.0%
2011	- CAD	0.0%
2010	- CAD	0.0%
2009	- CAD	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q3	550.39 Thousand CAD	178.05%
2024 FY	245.23 Thousand CAD	-44.29%
2024 Q4	245.23 Thousand CAD	-55.44%
2024 Q1	322.16 Thousand CAD	-26.81%
2024 Q2	197.94 Thousand CAD	-38.56%
2023 Q1	757.8 Thousand CAD	-15.71%
2023 FY	440.17 Thousand CAD	-51.04%
2023 Q4	440.17 Thousand USD	-22.35%
2023 Q3	566.85 Thousand CAD	-14.13%
2023 Q2	660.13 Thousand CAD	-12.89%
2022 Q3	73.12 Thousand CAD	1.96%
2022 FY	899.07 Thousand CAD	0.0%
2022 Q4	899.07 Thousand CAD	1129.47%
2022 Q2	71.72 Thousand CAD	-87.42%
2022 Q1	570.34 Thousand CAD	0.0%
2021 Q4	- CAD	-100.0%
2021 Q2	3.26 Million CAD	-0.25%
2021 FY	- CAD	-100.0%
2021 Q1	3.27 Million CAD	-29.33%
2021 Q3	3.25 Million CAD	-0.37%
2020 Q3	776.75 Thousand CAD	-4.39%
2020 FY	4.63 Million CAD	328916.69%
2020 Q1	863.92 Thousand CAD	61237.21%
2020 Q2	812.4 Thousand CAD	-5.96%
2020 Q4	4.63 Million CAD	496.61%
2019 Q4	1408.49 CAD	0.0%
2019 Q3	- CAD	0.0%
2019 Q2	- CAD	0.0%
2019 FY	1408.49 CAD	-99.43%
2019 Q1	- CAD	0.0%
2018 Q4	- CAD	-100.0%
2018 Q3	259.4 Thousand CAD	0.0%
2018 Q2	- CAD	0.0%
2018 Q1	- CAD	0.0%
2018 FY	245.37 Thousand CAD	0.0%
2017 Q4	- CAD	0.0%
2017 Q2	- CAD	0.0%
2017 FY	- CAD	0.0%
2017 Q1	- CAD	0.0%
2017 Q3	- CAD	0.0%
2016 Q3	- CAD	0.0%
2016 FY	- CAD	0.0%
2016 Q2	- CAD	0.0%
2016 Q1	- CAD	0.0%
2016 Q4	- CAD	0.0%
2015 Q4	- CAD	0.0%
2015 FY	- CAD	0.0%
2015 Q3	- CAD	0.0%
2015 Q2	- CAD	0.0%
2015 Q1	- CAD	0.0%
2014 Q3	- CAD	0.0%
2014 Q2	- CAD	0.0%
2014 Q1	- CAD	0.0%
2014 FY	- CAD	0.0%
2014 Q4	- CAD	0.0%
2013 Q4	- CAD	0.0%
2013 Q1	- CAD	0.0%
2013 Q2	- CAD	0.0%
2013 FY	- CAD	0.0%
2013 Q3	- CAD	0.0%
2012 Q1	- CAD	0.0%
2012 Q2	- CAD	0.0%
2012 Q3	- CAD	0.0%
2012 Q4	- CAD	0.0%
2012 FY	- CAD	0.0%
2011 FY	- CAD	0.0%
2011 Q1	- CAD	0.0%
2011 Q2	- CAD	0.0%
2011 Q3	- CAD	0.0%
2011 Q4	- CAD	0.0%
2010 FY	- CAD	0.0%
2010 Q4	- CAD	0.0%
2009 FY	- CAD	0.0%

Peer Long Term Debt Comparison of BetterLife Pharma Inc.

Name	Long Term Debt	Long Term Debt Difference
Eiger BioPharmaceuticals, Inc.	- USD	-Infinity%
Nanobac Pharmaceuticals, Incorporated	- USD	-Infinity%
SQZ Biotechnologies Company	20.9 Million USD	98.827%
Evofem Biosciences, Inc.	8000.00 USD	-2965.425%
Santhera Pharmaceuticals Holding AG	1.75 Million USD	86.03%
Mesoblast Limited	100.29 Million USD	99.755%
Propanc Biopharma, Inc.	58.64 Thousand USD	-318.188%
Genus plc	228.2 Million USD	99.893%
VioQuest Pharmaceuticals, Inc.	- USD	-Infinity%
CNBX Pharmaceuticals Inc.	- USD	-Infinity%
Marizyme, Inc.	667.12 Thousand USD	63.24%
ContraFect Corporation	2.21 Million USD	88.903%
Nymox Pharmaceutical Corporation	- USD	-Infinity%
PsyBio Therapeutics Corp.	- USD	-Infinity%
Sienna Biopharmaceuticals, Inc.	- USD	-Infinity%
RegeneRx Biopharmaceuticals, Inc.	1.4 Million USD	82.52%
Intellipharmaceutics International Inc.	- USD	-Infinity%
AXIM Biotechnologies, Inc.	5.42 Million USD	95.481%
MultiCell Technologies, Inc.	36.43 USD	-673064.974%
Accustem Sciences Inc.	- USD	-Infinity%
RVL Pharmaceuticals plc	55.61 Million USD	99.559%
EV Biologics, Inc.	- USD	-Infinity%
Q BioMed Inc.	- USD	-Infinity%
Emmaus Life Sciences, Inc.	2.22 Million USD	88.983%
Neon Bloom, Inc.	- USD	-Infinity%
Mosaic ImmunoEngineering Inc.	1.22 Million USD	80.036%
Biomind Labs Inc.	- USD	-Infinity%
TetraLogic Pharmaceuticals Corporation	- USD	-Infinity%
Pharming Group N.V.	166.1 Million USD	99.852%
Oncotelic Therapeutics, Inc.	1.89 Million USD	87.083%
Skye Bioscience, Inc.	171.23 Thousand USD	-43.219%
Therapeutic Solutions International, Inc.	5512.00 USD	-4349.093%
THC Farmaceuticals, Inc.	- USD	-Infinity%
Arch Therapeutics, Inc.	- USD	-Infinity%
IMV Inc.	27.39 Million USD	99.105%
Acro Biomedical Co., Ltd.	- USD	-Infinity%
Curative Biotechnology, Inc.	- USD	-Infinity%
GB Sciences, Inc.	322 Thousand USD	23.84%
Alpha Cognition Inc.	- USD	-Infinity%
HST Global, Inc.	- USD	-Infinity%
CSL Limited	11.23 Billion USD	99.998%
Halberd Corporation	150 Thousand USD	-63.489%
Enzolytics Inc.	- USD	-Infinity%
Resverlogix Corp.	- USD	-Infinity%
Affymax, Inc.	- USD	-Infinity%
SYBLEU INC	300 Thousand USD	18.255%
Nuo Therapeutics, Inc.	164.2 Thousand USD	-49.346%
argenx SE	15.35 Million USD	98.403%
MetaStat, Inc.	- USD	-Infinity%
Northwest Biotherapeutics, Inc.	20.31 Million USD	98.793%
Enzon Pharmaceuticals, Inc.	- USD	-Infinity%
Arno Therapeutics, Inc.	- USD	-Infinity%
RespireRx Pharmaceuticals Inc.	- USD	-Infinity%
GeneThera, Inc.	- USD	-Infinity%
Inhibitor Therapeutics, Inc.	- USD	-Infinity%
AVAX Technologies, Inc.	- USD	-Infinity%
Zenith Capital Corp.	4456.00 USD	-5403.456%
Genscript Biotech Corporation	287.12 Million USD	99.915%
Ember Therapeutics, Inc.	- USD	-Infinity%
Anthera Pharmaceuticals, Inc.	- USD	-Infinity%
Sigyn Therapeutics, Inc.	126.3 Thousand USD	-94.165%
WPD Pharmaceuticals Inc.	229.29 Thousand USD	-6.953%
American Oriental Bioengineering, Inc.	554.59 Thousand USD	55.781%
Provectus Biopharmaceuticals, Inc.	25.29 Thousand USD	-869.343%
Adynxx, Inc.	- USD	-Infinity%
Helix BioMedix, Inc.	- USD	-Infinity%
GlobeStar Therapeutics Corporation	- USD	-Infinity%
VitaSpring Biomedical Co. Ltd.	- USD	-Infinity%
Capstone Therapeutics Corp.	8.26 Million USD	97.033%
Cotinga Pharmaceuticals Inc.	- USD	-Infinity%
BioStem Technologies, Inc.	265.63 Thousand USD	7.68%
ONE Bio Corp.	592.19 Thousand USD	58.589%
Reve Technologies, Inc.	1064.00 USD	-22948.308%
Burzynski Research Institute, Inc.	- USD	-Infinity%
Wesana Health Holdings Inc.	- USD	-Infinity%
Agentix Corp.	- USD	-Infinity%
LadRx Corporation	- USD	-Infinity%
Cell Source, Inc.	- USD	-Infinity%
ProtoKinetix, Incorporated	- USD	-Infinity%
Regen BioPharma, Inc.	149.61 Thousand USD	-63.911%
Regen BioPharma, Inc.	149.61 Thousand USD	-63.911%
NovAccess Global Inc.	- USD	-Infinity%
Endonovo Therapeutics, Inc.	- USD	-Infinity%
Itoco Inc.	- USD	-Infinity%
Rasna Therapeutics, Inc.	- USD	-Infinity%
Pathfinder Cell Therapy, Inc.	- USD	-Infinity%
Kadimastem Ltd	229.69 Thousand USD	-6.767%
Oncology Pharma Inc.	- USD	-Infinity%
Institute of Biomedical Research Corp.	- USD	-Infinity%
CytoDyn Inc.	141 Thousand USD	-73.925%
Claritas Pharmaceuticals, Inc.	- USD	-Infinity%
NDT Pharmaceuticals Inc.	- USD	-Infinity%
Mobile Lads Corp.	- USD	-Infinity%
NanoSphere Health Sciences Inc.	- USD	-Infinity%
Qrons Inc.	80 Thousand USD	-206.543%
Alseres Pharmaceuticals, Inc.	7.81 Million USD	96.864%
Advanced Proteome Therapeutics Corporation	- USD	-Infinity%
Nascent Biotech, Inc.	- USD	-Infinity%
Rebus Holdings, Inc.	- USD	-Infinity%
ImmunoCellular Therapeutics, Ltd.	369.04 Thousand USD	33.55%
International Stem Cell Corporation	445 Thousand USD	44.891%
Bioxytran, Inc.	- USD	-Infinity%
GlobeImmune, Inc.	- USD	-Infinity%
Predictive Technology Group, Inc.	- USD	-Infinity%
ProText Mobility, Inc.	- USD	-Infinity%
Cardax, Inc.	- USD	-Infinity%
VG Life Sciences Inc.	- USD	-Infinity%
Kaleido Biosciences, Inc.	- USD	-Infinity%
Advaxis, Inc.	8.15 Million USD	96.991%
Adhera Therapeutics, Inc.	- USD	-Infinity%
RenovaCare, Inc.	- USD	-Infinity%
Regnum Corp.	- USD	-Infinity%
Innovation Pharmaceuticals Inc.	457 Thousand USD	46.338%
Neutra Corp.	- USD	-Infinity%
Windtree Therapeutics, Inc.	1.16 Million USD	78.877%
PureTech Health plc	18.25 Million USD	98.656%
Coeptis Therapeutics, Inc.	150 Thousand USD	-63.489%
IXICO plc	275 Thousand USD	10.824%
IntelGenx Technologies Corp.	11.83 Million USD	97.929%
Gelesis Holdings, Inc.	26.3 Million USD	99.068%
CSL Limited	11.23 Billion USD	99.998%
Cellectis S.A.	36.21 Million USD	99.323%

Global Stocks Search

BetterLife Pharma Inc. (BETRF)

Long Term Debt Summary of BetterLife Pharma Inc.

Annual Long Term Debt Chart of BetterLife Pharma Inc. (2024 - 2009)

Historical Annual Long Term Debt of BetterLife Pharma Inc. (2024 - 2009)

Peer Long Term Debt Comparison of BetterLife Pharma Inc.